1. A novel form of factor VII in plasma from men at risk for cardiovascular disease;Dalaker, K.; Hjermann, I.; Prydz, H.;Brit J Haematol,1985
2. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study;Meade, T.W.; Mellows, S.; Brozovic, M.;Lancet,1986
3. Swedish Aspirin Low-Dose Trial (SALT) of 75mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events;Group, The S.A.L.T.Collaborative;Lancet,1991
4. Davies Jones G A B. Systemic diseases, Ptl;Greaves, M.,1992
5. Antiphospholipid antibodies are directed against a binding inhibitor of coagulation: cJom-pgllyecxoparnottiegienn that includes a;McNeil, H.P.; Simpson, R.J.; Chesterman, C.N.; Krilis, S.A.,1990